Speciality:
Diagnosis of various benign and malignant tumors, precision radiotherapy, combined radio-chemotherapy, molecular targeted therapy, cellular immunotherapy (biological therapy), and the management of adverse reactions. She possesses particularly abundant and unique experience in the precision diagnosis and treatment of nasopharyngeal carcinoma, head and neck tumors, lung cancer, and primary or metastatic intracranial malignant tumors. She is highly skilled in the clinical application of the advanced precision stereotactic radiosurgery robotic system — the CyberKnife.
Director Lu Qiuxia has chaired one municipal-level scientific research project and participated in multiple municipal-level research projects. She has published over 10 papers in national and provincial-level oncology specialty journals.
Position:
Member, Committee of Radiation Oncology,Guangdong Association of Primary Medicine
Member, Multidisciplinary Diagnosis and Treatment Committee for Esophageal Diseases,Guangdong Association of Thoracic Diseases
Member, Association for Integrated Traditional Chinese and Western Medicine in Lung Cancer Rehabilitation and Treatment, Guangdong Medical Education Association
Standing Committee Member, Committee of Radiation Oncology, Guangdong Medical Women's Association
Member, Committee of Radiation Oncology, Nasopharyngeal Carcinoma, Tumor Imaging, Cancer Rehabilitation and Palliative Care, and Head and Neck Oncology, the China Anti-Cancer Association (CACA)
Director Lu Qiuxia and all medical staff at the Medical Oncology Precision Diagnosis and Treatment Center.
Director Lu Qiuxia participated in a China-U.S. Multidisciplinary Team (MDT) consultation.
Director Lu Qiuxia with other physicians at the Oncology Center.
Director Lu Qiuxia delivered a speech at the Radiosurgery Summit Forum.
Dr. Lu Qiuxia communicated with a patient about their condition in the ward.
